On March 19, 2025, Basel Medical Group Ltd announced the exercise of an overallotment option for 330,750 additional shares at $4.00 each, bringing total proceeds from its IPO to approximately $10.14 million. The initial offering included 2,205,000 shares, started trading on February 25, 2025, under the ticker 'BMGL'.